Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 79

1.

Access to diagnosis, treatment, and supportive services among pharmacotherapy-treated children/adolescents with ADHD in Europe: data from the Caregiver Perspective on Pediatric ADHD survey.

Fridman M, Banaschewski T, Sikirica V, Quintero J, Chen KS.

Neuropsychiatr Dis Treat. 2017 Mar 30;13:947-958. doi: 10.2147/NDT.S128752. eCollection 2017.

2.

Attention-Deficit/Hyperactivity Disorder.

Banaschewski T, Becker K, Döpfner M, Holtmann M, Rösler M, Romanos M.

Dtsch Arztebl Int. 2017 Mar 3;114(9):149-159. doi: 10.3238/arztebl.2017.0149.

3.

Cardiovascular Effects of Stimulant and Non-Stimulant Medication for Children and Adolescents with ADHD: A Systematic Review and Meta-Analysis of Trials of Methylphenidate, Amphetamines and Atomoxetine.

Hennissen L, Bakker MJ, Banaschewski T, Carucci S, Coghill D, Danckaerts M, Dittmann RW, Hollis C, Kovshoff H, McCarthy S, Nagy P, Sonuga-Barke E, Wong IC, Zuddas A, Rosenthal E, Buitelaar JK; ADDUCE consortium..

CNS Drugs. 2017 Mar;31(3):199-215. doi: 10.1007/s40263-017-0410-7. Review.

4.

Factors associated with caregiver burden among pharmacotherapy-treated children/adolescents with ADHD in the Caregiver Perspective on Pediatric ADHD survey in Europe.

Fridman M, Banaschewski T, Sikirica V, Quintero J, Erder MH, Chen KS.

Neuropsychiatr Dis Treat. 2017 Feb 7;13:373-386. doi: 10.2147/NDT.S121391. eCollection 2017.

5.

Diet and ADHD, Reviewing the Evidence: A Systematic Review of Meta-Analyses of Double-Blind Placebo-Controlled Trials Evaluating the Efficacy of Diet Interventions on the Behavior of Children with ADHD.

Pelsser LM, Frankena K, Toorman J, Rodrigues Pereira R.

PLoS One. 2017 Jan 25;12(1):e0169277. doi: 10.1371/journal.pone.0169277. eCollection 2017.

6.

Comparative efficacy and tolerability of pharmacological interventions for attention-deficit/hyperactivity disorder in children, adolescents and adults: protocol for a systematic review and network meta-analysis.

Cortese S, Adamo N, Mohr-Jensen C, Hayes AJ, Bhatti S, Carucci S, Del Giovane C, Atkinson LZ, Banaschewski T, Simonoff E, Zuddas A, Barbui C, Purgato M, Steinhausen HC, Shokraneh F, Xia J, Cipriani A, Coghill D; European ADHD Guidelines Group (EAGG)..

BMJ Open. 2017 Jan 10;7(1):e013967. doi: 10.1136/bmjopen-2016-013967.

7.

Diagnosis, treatment, and burden of illness among adults with attention-deficit/hyperactivity disorder in Europe.

Able SL, Haynes V, Hong J.

Pragmat Obs Res. 2014 Jul 28;5:21-33. eCollection 2014.

8.
9.

Meditation or Medication? Mindfulness training versus medication in the treatment of childhood ADHD: a randomized controlled trial.

Meppelink R, de Bruin EI, Bögels SM.

BMC Psychiatry. 2016 Jul 26;16:267. doi: 10.1186/s12888-016-0978-3.

10.

Sweat it out? The effects of physical exercise on cognition and behavior in children and adults with ADHD: a systematic literature review.

Den Heijer AE, Groen Y, Tucha L, Fuermaier AB, Koerts J, Lange KW, Thome J, Tucha O.

J Neural Transm (Vienna). 2017 Feb;124(Suppl 1):3-26. doi: 10.1007/s00702-016-1593-7. Epub 2016 Jul 11. Review.

11.

Comparative efficacy of methylphenidate and atomoxetine in the treatment of attention deficit hyperactivity disorder in children and adolescents: A systematic review and meta-analysis.

Rezaei G, Hosseini SA, Akbari Sari A, Olyaeemanesh A, Lotfi MH, Yassini M, Bidaki R, Nouri B.

Med J Islam Repub Iran. 2016 Feb 10;30:325. eCollection 2016.

12.

Guanfacine extended release for children and adolescents with attention-deficit/hyperactivity disorder: efficacy following prior methylphenidate treatment.

Huss M, Sikirica V, Hervas A, Newcorn JH, Harpin V, Robertson B.

Neuropsychiatr Dis Treat. 2016 May 5;112:1085-101. doi: 10.2147/NDT.S94158. eCollection 2016.

13.

Prospective observational study protocol to investigate long-term adverse effects of methylphenidate in children and adolescents with ADHD: the Attention Deficit Hyperactivity Disorder Drugs Use Chronic Effects (ADDUCE) study.

Inglis SK, Carucci S, Garas P, Häge A, Banaschewski T, Buitelaar JK, Dittmann RW, Falissard B, Hollis C, Kovshoff H, Liddle E, McCarthy S, Nagy P, Neubert A, Rosenthal E, Sonuga-Barke E, Wong I, Zuddas A, Coghill DC; ADDUCE Consortium..

BMJ Open. 2016 Apr 26;6(4):e010433. doi: 10.1136/bmjopen-2015-010433.

15.

Association of screen time with self-perceived attention problems and hyperactivity levels in French students: a cross-sectional study.

Montagni I, Guichard E, Kurth T.

BMJ Open. 2016 Feb 26;6(2):e009089. doi: 10.1136/bmjopen-2015-009089.

16.

The Effects of Classroom Interventions on Off-Task and Disruptive Classroom Behavior in Children with Symptoms of Attention-Deficit/Hyperactivity Disorder: A Meta-Analytic Review.

Gaastra GF, Groen Y, Tucha L, Tucha O.

PLoS One. 2016 Feb 17;11(2):e0148841. doi: 10.1371/journal.pone.0148841. eCollection 2016. Review.

17.

Biochemical and Psychological Effects of Omega-3/6 Supplements in Male Adolescents with Attention-Deficit/Hyperactivity Disorder: A Randomized, Placebo-Controlled, Clinical Trial.

Matsudaira T, Gow RV, Kelly J, Murphy C, Potts L, Sumich A, Ghebremeskel K, Crawford MA, Taylor E.

J Child Adolesc Psychopharmacol. 2015 Dec;25(10):775-82. doi: 10.1089/cap.2015.0052.

18.

Effective management of attention-deficit/hyperactivity disorder (ADHD) through structured re-assessment: the Dundee ADHD Clinical Care Pathway.

Coghill D, Seth S.

Child Adolesc Psychiatry Ment Health. 2015 Nov 19;9:52. doi: 10.1186/s13034-015-0083-2. eCollection 2015.

19.

Guanfacine Extended Release: A New Pharmacological Treatment Option in Europe.

Huss M, Chen W, Ludolph AG.

Clin Drug Investig. 2016 Jan;36(1):1-25. doi: 10.1007/s40261-015-0336-0. Review.

20.

Acute Effects of Whole Body Vibration on Inhibition in Healthy Children.

den Heijer AE, Groen Y, Fuermaier AB, van Heuvelen MJ, van der Zee EA, Tucha L, Tucha O.

PLoS One. 2015 Nov 2;10(11):e0140665. doi: 10.1371/journal.pone.0140665. eCollection 2015.

Supplemental Content

Support Center